CCM
TNDM icon

Copernicus Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Copernicus Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-42,685
Closed -$2.75M – 25
2020
Q1 		$2.75M Sell
42,685
-7,315
-15% -$513K 3.32% 12
2019
Q4 		$2.98M Buy
+50,000
New +$3.08M 3.91% 11

Other funds holding TNDM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Copernicus Capital Management's TNDM Position: Q2 2020 in Review

Copernicus Capital Management sold out of Tandem Diabetes Care (TNDM) in Q2 2020, closing a stake of 42,685 shares — an estimated $2.75M sold.

Copernicus Capital Management first reported a position in TNDM in Q4 2019 and held it in 2 quarters. The position peaked at $2.98M in Q4 2019. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2020.

  • Copernicus Capital Management reported no remaining Tandem Diabetes Care position as of Q2 2020 after selling out during the quarter.
  • Copernicus Capital Management sold 42,685 Tandem Diabetes Care shares in Q2 2020, an estimated $2.75M.
  • Copernicus Capital Management first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 2 quarters.
  • Copernicus Capital Management's Tandem Diabetes Care position peaked at $2.98M in Q4 2019.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2020.

Based on Copernicus Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.